Clinical Trial Update: Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission [Phase 1]

View source ↗

Summary

Phase 1 maintenance therapy trial evaluating decitabine alone or with venetoclax, gilteritinib, enasidenib, or ivosidenib in AML in remission; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Enasidenib (enasidenib)
• Gilteritinib (gilteritinib)
• Ivosidenib (ivosidenib)
• Venetoclax (venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING